LIFESTANCE HEALTH GROUP INC (LFST) Fundamental Analysis & Valuation

NASDAQ:LFST • US53228F1012

Current stock price

6.51 USD
+0.05 (+0.77%)
At close:
6.5176 USD
+0.01 (+0.12%)
After Hours:

This LFST fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LFST Profitability Analysis

1.1 Basic Checks

  • LFST had positive earnings in the past year.
  • In the past year LFST had a positive cash flow from operations.
  • In the past 5 years LFST reported 4 times negative net income.
  • LFST had a positive operating cash flow in 4 of the past 5 years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • LFST has a Return On Assets (0.44%) which is in line with its industry peers.
  • LFST's Return On Equity of 0.64% is in line compared to the rest of the industry. LFST outperforms 54.00% of its industry peers.
  • LFST has a Return On Invested Capital of 0.97%. This is in the lower half of the industry: LFST underperforms 62.00% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROIC 0.97%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.68%, LFST is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • The Operating Margin of LFST (1.70%) is comparable to the rest of the industry.
  • LFST's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.7%
PM (TTM) 0.68%
GM N/A
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LFST Health Analysis

2.1 Basic Checks

  • LFST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, LFST has more shares outstanding
  • LFST has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LFST has an improved debt to assets ratio.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.47 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LFST has a Altman-Z score of 2.47. This is comparable to the rest of the industry: LFST outperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of LFST is 2.55, which is a good value as it means it would take LFST, 2.55 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LFST (2.55) is better than 71.00% of its industry peers.
  • LFST has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • LFST's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. LFST outperforms 71.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Altman-Z 2.47
ROIC/WACC0.11
WACC8.69%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.65 indicates that LFST should not have too much problems paying its short term obligations.
  • LFST has a better Current ratio (1.65) than 66.00% of its industry peers.
  • LFST has a Quick Ratio of 1.65. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.65, LFST is doing good in the industry, outperforming 67.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. LFST Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 112.50% over the past year.
  • The Revenue has grown by 13.85% in the past year. This is quite good.
  • The Revenue has been growing by 30.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 134.65% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 14.35% on average over the next years. This is quite good.
EPS Next Y240.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue Next Year15.26%
Revenue Next 2Y14.64%
Revenue Next 3Y14.35%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. LFST Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 325.50, which means the current valuation is very expensive for LFST.
  • The rest of the industry has a similar Price/Earnings ratio as LFST.
  • When comparing the Price/Earnings ratio of LFST to the average of the S&P500 Index (27.34), we can say LFST is valued expensively.
  • Based on the Price/Forward Earnings ratio of 95.73, the valuation of LFST can be described as expensive.
  • LFST's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. LFST is more expensive than 62.00% of the companies in the same industry.
  • LFST's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.18.
Industry RankSector Rank
PE 325.5
Fwd PE 95.73
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • LFST's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LFST is more expensive than 60.00% of the companies in the same industry.
  • LFST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.06
EV/EBITDA 32.32
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • LFST's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LFST's earnings are expected to grow with 134.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y186.93%
EPS Next 3Y134.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LFST Dividend Analysis

5.1 Amount

  • No dividends for LFST!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LFST Fundamentals: All Metrics, Ratios and Statistics

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (4/14/2026, 5:12:48 PM)

After market: 6.5176 +0.01 (+0.12%)

6.51

+0.05 (+0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners42.96%
Inst Owner Change0.04%
Ins Owners3.26%
Ins Owner Change1.32%
Market Cap2.54B
Revenue(TTM)1.42B
Net Income(TTM)9.66M
Analysts82.35
Price Target9.92 (52.38%)
Short Float %4.39%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)980.59%
Min EPS beat(2)100%
Max EPS beat(2)1861.18%
EPS beat(4)4
Avg EPS beat(4)532.13%
Min EPS beat(4)67.32%
Max EPS beat(4)1861.18%
EPS beat(8)8
Avg EPS beat(8)286.19%
EPS beat(12)9
Avg EPS beat(12)177.02%
EPS beat(16)11
Avg EPS beat(16)131.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.3%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.33%
Revenue beat(16)8
Avg Revenue beat(16)0.11%
PT rev (1m)9.37%
PT rev (3m)12.72%
EPS NQ rev (1m)-33.3%
EPS NQ rev (3m)33.4%
EPS NY rev (1m)17.65%
EPS NY rev (3m)60%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 325.5
Fwd PE 95.73
P/S 1.78
P/FCF 23.06
P/OCF 17.36
P/B 1.67
P/tB 50.75
EV/EBITDA 32.32
EPS(TTM)0.02
EY0.31%
EPS(NY)0.07
Fwd EY1.04%
FCF(TTM)0.28
FCFY4.34%
OCF(TTM)0.37
OCFY5.76%
SpS3.65
BVpS3.9
TBVpS0.13
PEG (NY)1.36
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROCE 1.24%
ROIC 0.97%
ROICexc 1.11%
ROICexgc 8.12%
OM 1.7%
PM (TTM) 0.68%
GM N/A
FCFM 7.73%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-21.84%
ROICexc growth 3YN/A
ROICexc growth 5Y6.17%
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Debt/EBITDA 3.37
Cap/Depr 65.98%
Cap/Sales 2.54%
Interest Coverage 1.36
Cash Conversion 185.23%
Profit Quality 1138.63%
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 2.47
F-Score8
WACC8.69%
ROIC/WACC0.11
Cap/Depr(3y)48.92%
Cap/Depr(5y)87.16%
Cap/Sales(3y)2.7%
Cap/Sales(5y)6.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y240.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%
Revenue Next Year15.26%
Revenue Next 2Y14.64%
Revenue Next 3Y14.35%
Revenue Next 5YN/A
EBIT growth 1Y175.64%
EBIT growth 3YN/A
EBIT growth 5Y9.27%
EBIT Next Year1867.82%
EBIT Next 3Y209.01%
EBIT Next 5YN/A
FCF growth 1Y28.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.26%
OCF growth 3Y40.42%
OCF growth 5YN/A

LIFESTANCE HEALTH GROUP INC / LFST Fundamental Analysis FAQ

What is the fundamental rating for LFST stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFST.


Can you provide the valuation status for LIFESTANCE HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.


How profitable is LIFESTANCE HEALTH GROUP INC (LFST) stock?

LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 2 / 10.


What is the financial health of LIFESTANCE HEALTH GROUP INC (LFST) stock?

The financial health rating of LIFESTANCE HEALTH GROUP INC (LFST) is 5 / 10.